Skip to main content
Watch Insiders
RARE filings

Corporate insider profile

Howard Horn Filing Activity

Latest reported as Chief Financial Officer of Ultragenyx Pharmaceutical Inc. (RARE).

Purchase filings
0
Reported companies
1
Net open-market value
-$499,877.57
Latest transaction
Aug 3, 2026

Affiliated corporations

Reported company relationships

RARELatest reported

Ultragenyx Pharmaceutical Inc.

Chief Financial Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 3, 2026Ultragenyx Pharmaceutical Inc. (RARE)Chief Financial OfficerSale4,696$24.92$117,024
Jul 1, 2026Ultragenyx Pharmaceutical Inc. (RARE)Chief Financial OfficerSale4,698$33.13$155,645
Jun 1, 2026Ultragenyx Pharmaceutical Inc. (RARE)Chief Financial OfficerSale4,653$23.77$110,602
🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium